NASDAQ Stock Exchange

Tickers analyzed: 2 829 | Updated: 2019-12-13 | Next Update: 2019-12-16

1252 Buy Candidates
583 Hold Candidates
994 Sell Candidates

Today's Case: TG Therapeutics (TGTX)

Friday December 13, 2019 Change 7.50% Price $10.10
Your prediction: Prediction: Request
VOLUME
Buy
TREND
Buy
MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy
Bullish vs. Bearish (6 opinions)
83%
17%
Social Sentiment 0.52

TGTX Forecast and Technical Stock Analysis


Buy candidate since 2019-12-09 Gain 8.84% PDF

TG Therapeutics gained 7.50% in the last trading day ( Friday, 13th Dec 2019 ), rising from $9.40 to $10.10 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 13.53% from a day low at $9.50 to a day high of $10.79. The price has been going up and down for this period, and there has been a 23.32% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 2.59 million more shares were traded than the day before. In total, 4.93 million shares bought and sold for approximately $49.75 million.

Quick summary:

  • 30 day high of the TGTX stock price was $10.79 and low was $7.04.
  • 90 day high was $10.79 and low was $4.95.
  • 52 week high for TG Therapeutics - $10.79 and low - $3.32.
Top Trending Stocks

Trend

TG Therapeutics has broken the very wide and strong rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $9.60, a level that may pose a second chance to hit a runner. According to fan-theory $11.78 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.

Top Golden Star Stocks

Signals

Only positive signals in the chart today. TG Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $8.85 and $7.83. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday December 11, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

A sell signal from a double top formation was found on Wednesday December 04, 2019 and based on theory for this formation the price should fall by -0.72% to $7.47 within 3 trading days since signal was issued (Monday December 09, 2019).

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 68 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $9.42 and $9.28.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, TG Therapeutics finds support just below today's level at $9.42. If this is broken, then the next support from accumulated volume will be at $9.28 and $7.81.

Support: $9.42 Price: $10.10

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.29 between high and low, or 13.53%. For the last week, the stock has had a daily average volatility of 11.81%.

Our recommended stop-loss: $9.64 (-4.58%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)

11.81 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Strong Buy Candidate Upgraded

Evaluation

Several short-term signals are positive and the stock has broke the rising trend up, which indicates an even stronger rising rate. We conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term period.

Top Buy Candidates

TG Therapeutics

Chg: 7.5% Price: $10.10

Preferred Bank

Chg: 0.67% Price: $57.29

TTM Technologies

Chg: 6.45% Price: $14.68

Capital Product Partners L.P.

Chg: 1.19% Price: $11.91

Top Sell Candidates

Sabra Healthcare REIT

Chg: -1.34% Price: $20.56

Lovesac Company

Chg: -9.06% Price: $10.74

Anixa Biosciences Inc.

Chg: -15.1% Price: $3.26

Golden Crosses

I.D. Systems

Change: 0.66% Price: $6.07

Entegra Financial Corp.

Change: 0.03% Price: $30.11

CHS Inc

Change: 0.55% Price: $27.64